1. Home
  2. MTLS vs EOLS Comparison

MTLS vs EOLS Comparison

Compare MTLS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Materialise NV

MTLS

Materialise NV

HOLD

Current Price

$5.01

Market Cap

311.1M

Sector

Technology

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.02

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTLS
EOLS
Founded
1990
2012
Country
Belgium
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.1M
284.3M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
MTLS
EOLS
Price
$5.01
$4.02
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
85.5K
1.1M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$6.38
$13.27
Revenue Next Year
$6.45
$17.62
P/E Ratio
$61.39
N/A
Revenue Growth
N/A
11.61
52 Week Low
$3.93
$3.86
52 Week High
$6.80
$12.28

Technical Indicators

Market Signals
Indicator
MTLS
EOLS
Relative Strength Index (RSI) 44.84 37.79
Support Level $4.94 N/A
Resistance Level $5.44 $4.99
Average True Range (ATR) 0.17 0.23
MACD 0.01 -0.07
Stochastic Oscillator 35.48 12.83

Price Performance

Historical Comparison
MTLS
EOLS

About MTLS Materialise NV

Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: